Novel Radiopharmaceutical Beats Cabazitaxel in mCRPC
A novel radiopharmaceutical was more active than cabazitaxel against metastatic castration-resistant prostate cancer (mCRPC) and caused fewer grade 3/4 adverse …
Home ยป
A novel radiopharmaceutical was more active than cabazitaxel against metastatic castration-resistant prostate cancer (mCRPC) and caused fewer grade 3/4 adverse …
Red ginseng, which has long been used as an ingredient in traditional Korean medicine, has recently drawn increased attention as …
Colorectal sarcoma is a very rare type of mesenchymal cancer that develops in the lower gastrointestinal (GI) tract. Image Credit: …
Cold Spring Harbor Laboratory (CSHL) scientists have discovered a gene-regulating snippet of RNA that may contribute to the spread of …
The Research Team reports the establishment of B6Ca P, an allograft tumor line from a Hi-Myc transgenic mouse that had …